Paratek Pharma Inc (PRTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 42,810 | 45,151 | 34,373 | 27,212 | 39,505 |
| Marketable Securities | N/A | N/A | N/A | 29,922 | 29,886 |
| Receivables | 42,511 | 37,166 | 78,038 | 32,739 | 31,818 |
| Inventories | 11,413 | 13,989 | 16,565 | 20,750 | 13,083 |
| TOTAL | $105,227 | $111,014 | $136,842 | $121,341 | $127,768 |
| Non-Current Assets | |||||
| PPE Net | 554 | 601 | 616 | 663 | 712 |
| Intangibles | 829 | 829 | 829 | 829 | 829 |
| Other Non-Current Assets | 39,182 | 38,384 | 34,251 | 34,488 | 34,386 |
| TOTAL | $40,565 | $39,814 | $35,696 | $35,980 | $35,927 |
| Total Assets | $145,792 | $150,828 | $172,538 | $157,321 | $163,695 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 164,042 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,951 | 5,318 | 5,308 | 8,107 | 2,257 |
| Accrued Expenses | 34,803 | 26,633 | 31,210 | 28,520 | 25,661 |
| Other current liabilities | 823 | 794 | 870 | 2,349 | 2,182 |
| TOTAL | $202,619 | $32,745 | $37,388 | $38,976 | $30,100 |
| Non-Current Liabilities | |||||
| Long Term Debt | 94,285 | 257,695 | 256,946 | 258,482 | 257,153 |
| Other Non-Current Liabilities | 50,253 | 49,426 | 49,246 | 25,394 | 25,809 |
| TOTAL | $144,538 | $307,121 | $306,192 | $284,497 | $282,962 |
| Total Liabilities | $347,157 | $339,866 | $343,580 | $323,473 | $313,062 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 57,322 | 57,282 | 57,265 | 55,549 | 54,863 |
| Common Shares | 57 | 57 | 56 | 55 | 55 |
| Retained earnings | -965,145 | -950,592 | -930,449 | -923,292 | -902,412 |
| Other shareholders' equity | 0 | 0 | 0 | -117 | -233 |
| TOTAL | $-201,365 | $-189,038 | $-171,042 | $-166,152 | $-149,367 |
| Total Liabilities And Equity | $145,792 | $150,828 | $172,538 | $157,321 | $163,695 |